Revision history of "Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma" (Q57028105)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

3 September 2024

9 July 2024

9 September 2023

11 October 2022

22 December 2021

2 November 2021

27 September 2021

13 August 2021

21 January 2021

4 August 2020

26 April 2020

7 November 2019

29 June 2019

13 June 2019

25 November 2018

7 October 2018